Guidelines for the use of molecular tests for the detection and genotyping of human papilloma virus from clinical specimens

Methods in Molecular Biology

Volumn 903, Issue , 2012, Pages 65-101

  Lee, Sin Hang ^a  

^a Milford Hospital   (United States)

Author keywords

DNA sequencing; Genotyping; HPV DNA; Nested PCR

Indexed keywords

HEMOGLOBIN BETA CHAIN; VIRUS DNA;

AGAR GEL ELECTROPHORESIS; ARTICLE; DNA CONTAMINATION; DNA SEQUENCE; FEMALE; GENETICS; GENOTYPING TECHNIQUE; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MOLECULAR DIAGNOSIS; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE;

BASE SEQUENCE; BETA-GLOBINS; DNA CONTAMINATION; DNA, VIRAL; ELECTROPHORESIS, AGAR GEL; FEMALE; GENOTYPING TECHNIQUES; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; MOLECULAR SEQUENCE DATA; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 84864829831     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-937-2_5     Document Type: Article

References (58)

1. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H (2004) Classi fi cation of papillomaviruses. Virology 324:17-27.
2. Chan SY, Delius H, Halpern AL, Bernard HU (1995) Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy. J Virol 69:3074-3083.
3. Meyer T, Arndt R, Stock fl eth E, Flammann HT, Wolf H, Reischl U (1995) Strategy for typing human papillomaviruses by RFLP analysis of PCR products and subsequent hybridization with a generic probe. Biotechniques 19:632-639.
4. Vernon SD, Unger ER, Williams D (2000) Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture. J Clin Microbiol 38:651-655. (Pubitemid 30082658)
5. Johnson T, Bryder K, Corbet S, Fomsgaard A (2003) Routine genotyping of human papillomavirus samples in Denmark. APMIS 111:398-404. (Pubitemid 36560539)
6. Speich N, Schmitt C, Bollmann. R, Bollmann M (2004) Human papillomavirus (HPV) study of 2916 cytological samples by PCR and DNA sequencing: genotype spectrum of patients from the west German area. J Med Microbiol 53:125-128. (Pubitemid 38223691)
7. Klug SJ, Molijn A, Schopp B, Holz B, Iftner A, Quint W, J F Snijders P, Petry KU, Krüger Kjaer S, Munk C, Iftner T (2008) Comparison of the performance of different HPV genotyping methods for detecting genital HPV types. J Med Virol 80:1264-1274. (Pubitemid 351706007)
8. Frutos AG, Pal S, Quesada M, Lahiri J (2002) Method for detection of single-base mismatches using bimolecular beacons. J Am Chem Soc 124:2396-2397. (Pubitemid 34251729)
9. Iqbal J, Hanel F, Ruryk A, Limmon GV, Tretiakov A, Durst M, Saluz HP (2008) Fabrication and evaluation of a sequencespeci fi c oligonucleotide miniarray for molecular genotyping. Indian J Med Microbiol 26:13-20. (Pubitemid 351197555)
10. Kinney W, Stoler MH, Castle PE (2010) Special commentary: patient safety and the next generation of HPV DNA tests. Am J Clin Pathol 134:193-199.
11. Draft Guidance for Industry issued by the U. S. Food and Drug Administration. Establishing the performance characteristics of in vitro diagnostic devices for the detection or detection and differentiation of human papillomaviruses. FDA Docket N.o. FDA-2009-D-0386-0002. Posted on 09-09-2009. http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/ GuidanceDocuments/UCM181511.pdf .
12. National Cancer Institute. HPV genotyping. Solicitation number: NCI-100143-MM. 2 Aug 2010. https://www.fbo.gov/index?s=opportunity&mode= form&id=da396b97ad6eb7ec4f7d511f85d9e325&tab=core&-cview=0.
13. Feoli-Fonseca JC, Oligny LL, Filion M, Brochu P, Simard P, Russo PA, Yotov WV (1998) A two-tier polymerase chain reaction direct sequencing method for detection and typing human papillomavirus in pathological specimens. Diagn Mol Pathol 7:317-323. (Pubitemid 29177574)
14. Asato T, Maehama T, Nagai Y, Kanazawa K, Uezato H, Kariya K (2004) A large case-control study of cervical cancer risk associated with human papillomavirus infection in Japan, by nucleotide sequencing-based genotyping. J Infect Dis 189:1829-1832. (Pubitemid 38657219)
15. Lee SH, Vigliotti VS, Vigliotti JS, Vigliotti JS, Pappu S (2007) Routine human papillomavirus genotyping by DNA sequencing in community hospital laboratories. Infect Agent Cancer 2:11.
16. Lee SH, Vigliotti VS, Pappu S (2009) Human papillomavirus (HPV) infection among women in a representative rural and suburban population of the United States. Inter J Gyn Ob 105:210-214.
17. Lee SH, Vigliotti VS, Pappu S (2009) Molecular tests for human papillomavirus (HPV), Chlamydia trachomatis and Neisseria gonorrhoeae in liquid-based cytology specimen. BMC Wom Health 9:8.
18. Lee SH, Vigliotti VS, Vigliotti JS, Pappu S (2009) Validation of human papillomavirus genotyping by signature DNA sequence analysis. BMC Clin Pathol 9:3.
19. Lee SH, Vigliotti VS, Pappu S (2010) Signature sequence validation of human papillomavirus type 16 (HPV-16) in clinical specimens. J Clin Pathol 63:235-239.
20. Carvalho Nde O, del Castillo DM, Perone C, Januário JN, de Melo VH, Brasileiro Filho G (2010) Comparison of HPV genotyping by type-speci fi c PCR and sequencing. Mem Inst Oswaldo Cruz 105:73-78.
21. Coutlée F, Rouleau D, Petignat P, Ghattas G, Kornegay JR, Schlag P, Boyle S, Hankins C, Vézina S, Coté P, Macleod J, Voyer H, Forest P, Walmsley S, Canadian Women's HIV study Group, Franco E (2006) Enhanced detectionand typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test. J Clin Microbiol 44:1998-2006. (Pubitemid 43902145)
22. Habis AH, Vernon SD, Lee DR, Verma M, Unger ER (2004) Molecular quality of exfoliated cervical cells: implications for molecular epidemiology and biomarker discovery. Cancer Epidemiol Biomarkers Prev 13:492-496. (Pubitemid 38737478)
23. Dunn ST, Allen RA, Wang S, Walker J, Schiffman M (2007) DNA extraction: an understudied and important aspect of HPV genotyping using PCR-based methods. J Virol Methods 143:45-54. (Pubitemid 46802824)
24. Sherman ME, Wang SS, Wheeler CM, Rich L, Gravitt PE, Tarone R, Schiffman M (2003) Determinants of human papillomavirus load among women with histological cervical intraepithelial neoplasia 3: dominant impact of surrounding low-grade lesions. Cancer Epidemiol Biomarkers Prev 12:1038-1044. (Pubitemid 37310260)
25. Sherman ME, Wang SS, Tarone R, Rich L, Schiffman M (2003) Histopathologic extent of cervical intraepithelial neoplasia 3 lesions in the atypical squamous cells of undetermined signi fi cance low-grade squamous intraepithelial lesion triage study: implications for subject safety and lead-time bias. Cancer Epidemiol Biomarkers Prev 12:372-379. (Pubitemid 36427999)
26. Garner-Hamrick PA, Fisher C (2002) HPV episomal copy number closely correlates with cell size in keratinocyte monolayer cultures. Virology 301:334-341. (Pubitemid 35176557)
27. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky S.M. Use of polymerase chain reaction ampli fi cation for the detection of genital human papillomaviruses. Cancer Cells 7/Molecular diagnostics of human cancer. 1989 Cold Spring Harbor Laboratory, pp 209-214.
28. Snijders PJ, van den Brule AJ, Schrijnemakers HF, Snow G, Meijer CJ, Walboomers JM (1990) The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virol 71:173-181. (Pubitemid 20046022)
29. Kwok S, Kellogg DE, McKinney N, Spasic D, Goda L, Levenson C, Sninsky JJ (1990) Effects of primer-template mismatches on the polymerase chain reaction: human immunode fi ciency virus type 1 model studies. Nucleic Acids Res 18:999-1005.
30. O'Dell SD, Humphries SE, Day IN (1996) PCR induction of a Taq I restriction site at any CpG dinucleotide using two mismatched primers (CpG-PCR). Genome Res 6:558-568. (Pubitemid 26202782)
31. U.S. Patent #6,165,765.
32. Lee SH, Vigliotti VS, Pappu S (2008) DNA sequencing validation of Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid tests. Am J Clin Pathol 129:852-859.
33. Lee SH, Vigliotti VS, Viglioti JS, Jones W, Pappu S (2010) Increased sensitivity and speci fi city of Borrelia burgdorferi 16S ribosomal DNA detection. Am J Clin Pathol 133:569-576.
34. Chien A, Edgar DB, Trela JM (1976) Deoxyribonucleic acid polymerase from the extreme thermophile Thermus aquaticus. J Bacteriol 127:1550-1557.
35. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlée F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ (2000) Improved ampli fi cation of genital human papillomaviruses. J Clin Microbiol 38:357-361. (Pubitemid 30043317)
36. Sahli R. Meeting report. WHO HPV LabNet training workshop on HPV genotyping and HPV serology laboratory performance. Lausanne, Switzerland 15-18 March 2010. http://www.who.int/biologicals/vaccines/hpv/HPV-Training-Workshop- CHUV-mTG-report-20052010.pdf.
37. Qu W, Jiang G, Cruz Y, Chang CJ, Ho GY, Klein RS, Burk RD (1997) PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 35:1304-1310. (Pubitemid 27216785)
38. Wang Y, Prosen DE, Mei L, Sullivan JC, Finney M, Vander-Horn PB (2004) A novel strategy to engineer DNA polymerases for enhanced processivity and improved performance in vitro. Nucleic Acids Res 32:1197-1207. (Pubitemid 38864677)
39. Earley JJ, Kuivaniemi H, Prockop DJ, Tromp G (1993) Ef fi cient DNA sequencing on microtiter plates using dried reagents and Bst DNA polymerase. DNA Seq 4:79-85. (Pubitemid 2038313)
40. Evans MF, Adamson CS, Simmons-Arnold L, Cooper K (2005) Touchdown general primer (GP5+/GP6+) PCR and optimized sample DNA concentration support the sensitive detection of human papillomavirus. BMC Clin Pathol 5:10.
41. Liu SS, Leung RC, Chan KK, Cheung AN, Ngan HY (2010) Evaluation of a newly developed GenoArray human papillomavirus (HPV) genotyping assay and comparison with the Roche Linear Array HPV genotyping assay. J Clin Microbiol 48:758-764.
42. Apfalter P, Assadian O, Blasi F, Boman J, Gaydos CA, Kundi M, Makristathis A, Nehr M, Rotter ML, Hirschl AM (2002) Reliability of nested PCR for detection of Chlamydiapneumoniae DNA in atheromas: results from a multicenter study applying standardized protocols. J Clin Microbiol 40:4428-4434. (Pubitemid 35434926)
43. Ayatollahi M, Zakerinia M, Haghshenas M (2005) Molecular analysis of Iranian families with sickle cell disease. J Trop Pediatr 51:136-140. (Pubitemid 41444456)
44. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 87:796-802.
45. Schiffman MH, Castle P (2003) Epidemiologic studies of a necessary causal risk factor: human papillomavirus infection and cervical neoplasia. J Natl Cancer Inst 95:E2.
46. Davey DD, Cox JT, Austin RM, Birdsong G, Colgan TJ, Howell LP, Husain M, Darragh TM (2008) Cervical cytology specimen adequacy: patient management guidelines and optimizing specimen collection. J Low Genit Tract Dis 12:71-81. (Pubitemid 351457911)
47. Didelot-Rousseau MN, Courgnaud V, Nagot N, Ouedraogo A, Konate I, Mayaud P, Weiss H, Van de Perre P, Segondy M (2006) Comparison of INNO-LiPA HPV Genotyping v2 with PCR product subcloning and sequencing for identi fi cation of genital human papillomavirus genotypes in African women. J Virol Methods 135:181-185. (Pubitemid 43922381)
48. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ (1995) The use of general primers GP5 and GP6 elongated at their 3ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76:1057-1062.
49. Wallin KL, Wiklund F, Angström T, Bergman F, Stendahl U, Wadell G, Hallmans G, Dillner J (1999) Type-speci fi c persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 341:1633-1638.
50. Kjaer SK, van den Brule AJ, Paull G, Svare EI, Sherman ME, Thomsen BL, Suntum M, Bock JE, Poll PA, Meijers CJ (2002) Type speci fi c persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ 325:572-576. (Pubitemid 35026129)
51. Cuschieri KS, Cubie HA, Whitley MW, Gilkison G, Arends MJ, Graham C, McGoogan E (2005) Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study. J Clin Pathol 58:946-950. (Pubitemid 41265279)
52. Coutlée F, Gravitt P, Kornegay J, Hankins C, Richardson H, Lapointe N, Voyer H, Franco E (2002) Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol 40:902-907. (Pubitemid 34208642)
53. Brown DR, Shew ML, Qadadri B, Neptune N, Vargas M, Tu W, Juliar BE, Breen TE, Fortenberry JD (2005) Longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis 191:182-192. (Pubitemid 40096375)
54. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE (2007) Prevalence of HPV infection among females in the United States. JAMA 297:813-819. (Pubitemid 46333946)
55. Check W (2010) HPV testing -proceed, with caution. CAP Today 24(October):1-74.
56. Stoler MH, Castle PE, Solomon D, Schiffman M (2007) The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assays. Am J Clin Pathol 127:1-3.
57. Schiffman M, Rodríguez AC (2008) Heterogeneity in CIN3 diagnosis. Lancet Oncol 9:404-406, A comment on the article. (Pubitemid 351618081)
58. McCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, Skegg DC (2008) Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 9:425-434.